CAPABLE: FINDINGS, COST SAVINGS, AND SCALING FROM AN AGING-IN-PLACE DEMONSTRATION
Szanton S., Gajardo J.
Prospective Study, published in Innov Aging (2017) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Innov Aging (2017)
- Reported sample size
- —
- Source database
- Europe PMC
- PMCID
- PMC6183530
Abstract (original English)
Abstract As the global population of older adults continues to expand, it is ever more urgent to identify promising programs that decrease disability. The Community Aging in Place, Advancing Better Living for Elders (CAPABLE) program, funded by the Center for Medicare and Medicaid Innovation, is designed to reduce the health impact of impaired physical function among low-income older adults by addressing both individual capacity and the home environment. Using an inter-professional team composed of an occupational therapist, nurse, and handyman, CAPABLE helps older adults attain self-identified functional goals. With clinician input, participants develop action plans to achieve their goals. Home repairs, assistive devices, and home modifications support these goals. In this symposium, we present overall results, and cost savings from a Center for Medicare and Medicaid Innovation (CMMI) project of CAPABLE, plus scaling possibilities, and current scaling of the program to new cities. The 1st presenter will report results and multivariable models of the primary outcomes from the CMMI trial. The 2nd presenter discuss the association between home hazards and disability The 3rd presenter will report an economic analysis of cost savings to Medicaid from the CAPABLE program. The 4th presenter will report results from testing CAPABLE in 3 cities in Michigan through a program called MI-C
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.